A Palo Alto-based firm focused on investing in digital health companies plans to raise a $150 million fund. According to documents filed with the Securities and Exchange Commission, Asset Management Ventures (AMV) is raising for its fifth fund, its largest yet.
Some of AMV’s past digital health investments include digital medicines company Proteus, diabetes digital assistant Welldoc and health data analytics company Evidation. The company has also seen some significant exits in biotechnology and software, such as with drug-developer Amgen and speech-recognition company Nuance.
When Investment Rhymes with Canada
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
AMV was created by one of Amgen’s founders, Pitch Johnson. The firm’s current partners include Skip Fleshman, founder of flight simulator company BGI; Dr. Lou Lange, former chief of cardiology at Jewish Hospital and founder of CV Therapeutics; and Rich Simoni, founder of internet video services company Talkway Communications.
Photo credit: aurielaki, Getty Images
